GANZI VICTOR F 4/A
4/A · Angion Biomedica Corp. · Filed May 27, 2022
Insider Transaction Report
Form 4/AAmended
GANZI VICTOR F
Director
Transactions
- Sale
Common Stock
2021-02-09$16.00/sh−246,720$3,947,520→ 823,117 total - Exercise of In-Money
Warrant to Purchase Common Stock
2021-02-09−614,310→ 0 totalExercise: $6.43Exp: 2028-07-05→ Common Stock (614,310 underlying) - Exercise of In-Money
Common Stock
2021-02-09$6.43/sh+614,310$3,950,013→ 1,069,837 total
Footnotes (1)
- [F1]On February 9, 2021 the Reporting Person exercised a warrant to purchase an aggregate of 614,310 shares of the Issuer's common stock for $6.43 a share. The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 246,720 of the warrant shares to pay the exercise price and issued the remaining 367,590 shares of common stock to Reporting Person.